Condensed Consolidated Statements of Redeemable Preferred Stock and Shareholders' Equity - USD ($) $ in Thousands	Total	Total Shareholders’ Equity	Common Stock	Paid in Capital in Excess of par	Retained Earnings	Accumulated Other Comprehensive Income	Redeemable Preferred Stock
Balances, beginning of period, redeemable preferred stock (in shares) at Dec. 31, 2023							2,500,000
Balances, beginning of period, redeemable preferred stock at Dec. 31, 2023							$ 49,964
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of preferred shares issuance costs	$ (12)						$ 12
Balances, end of period, redeemable preferred stock (in shares) at Mar. 31, 2024							2,500,000
Balances, end of period, redeemable preferred stock at Mar. 31, 2024							$ 49,976
Balances, beginning of period, common stock (in shares) at Dec. 31, 2023			6,849,000
Balances, beginning of period at Dec. 31, 2023		$ 438,963	$ 68	$ 29,667	$ 397,781	$ 11,447
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	20,869	20,869			20,869
Net unrealized loss from currency translation adjustment, net of tax benefit		(267)				(267)
Net unrealized loss from derivative instruments, net of tax benefit		(847)				(847)
Shares issued under stock compensation plans (in shares)			10,000
Shares issued under stock compensation plans		178	$ 1	177
Stock-based compensation expense, net of forfeitures		3,813		3,813
Accretion of preferred shares issuance costs		(12)			(12)
Preferred stock dividends		(900)			(900)
Balances, ending of period, common stock (in shares) at Mar. 31, 2024			6,859,000
Balances, end of period at Mar. 31, 2024		461,797	$ 69	33,657	417,738	10,333
Balances, beginning of period, redeemable preferred stock (in shares) at Dec. 31, 2024							3,250,000
Balances, beginning of period, redeemable preferred stock at Dec. 31, 2024	63,122						$ 63,122
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of preferred shares issuance costs	$ (70)						$ 70
Balances, end of period, redeemable preferred stock (in shares) at Mar. 31, 2025	3,250,000						3,250,000
Balances, end of period, redeemable preferred stock at Mar. 31, 2025	$ 63,192						$ 63,192
Balances, beginning of period, common stock (in shares) at Dec. 31, 2024	7,173,000		7,173,000
Balances, beginning of period at Dec. 31, 2024	$ 549,338	549,338	$ 72	50,928	491,439	6,899
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 16,869	16,869			16,869
Net unrealized loss from currency translation adjustment, net of tax benefit		4				4
Net unrealized loss from derivative instruments, net of tax benefit		(4,539)				(4,539)
Shares issued under stock compensation plans (in shares)			200,000
Shares issued under stock compensation plans		134	$ 2	132
Stock-based compensation expense, net of forfeitures		6,907		6,907
Accretion of preferred shares issuance costs		(70)			(70)
Common stock cash dividends paid		(1,832)			(1,832)
Preferred stock dividends		(1,323)			(1,323)
Balances, ending of period, common stock (in shares) at Mar. 31, 2025	7,373,000		7,373,000
Balances, end of period at Mar. 31, 2025	$ 565,488	$ 565,488	$ 74	$ 57,967	$ 505,083	$ 2,364